Clinical Trials Directory

Trials / Sponsors / Thirty Respiratory Limited

Thirty Respiratory Limited

Industry · 6 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingPhase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculo
Pulmonary Tuberculoses
Phase 22025-10-13
Active Not RecruitingNebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)
Non-Cystic Fibrosis Bronchiectasis
Phase 1 / Phase 22024-10-16
TerminatedEvaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberc
Rifampicin Susceptible Pulmonary Tuberculosis
Phase 22023-09-27
WithdrawnPREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)
Respiratory Viral Infection, Respiratory Tract Diseases, COVID-19 Respiratory Infection
Phase 2 / Phase 32021-09-01
TerminatedCOmmunity Patients at Risk of Viral Infections Including SARS-CoV-2
COPD, Bronchiectasis
Phase 22021-03-01
CompletedA Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospital
COVID-19
Phase 2 / Phase 32020-07-29